Dr
Madrid, Spain

Isabel T. Rubio is the Head of Breast Surgical Oncology at Clinica Universidad de Navarra and Professor of Surgery at the University of Navarra in Madrid, Spain. She studied medicine at the Faculty of Medicine in Salamanca, Spain, and become a Board certified General Surgeon. She had additional training for two year as a Breast Surgical Oncology Fellow at The University of Arkansas for Medical Sciences and the Arkansas Cancer Center at Little Rock, USA and for one year at the MD Anderson Cancer Center in Houston, Texas, USA. She has been Chief of Breast Surgical Oncology at Hospital Universitario Vall d´Hebron and Associate Professor of Surgery at Universitat Autónoma de Barcelona, Spain. (2009-2018). She is the director of the Breast Surgery Fellowship program at her Institution.
She obtained the European Board of Surgery Qualification in Breast Surgery and is an officer at the UEMS Breast Surgery Division. She participates as an examiner in the EBSQ Examinations in Breast Surgery.

Dr. Rubio is active in many societies, as President elect of the European Cancer Organization (ECO). Immediate past President of the European Society of Surgical Oncology (ESSO), EUSOMA past president (European Society of Breast Cancer Specialists), founding member and past President of the Spanish Association of Breast Surgeons (AECIMA), Founding member and Board member of EUBREAST, member of the Transforming Breast Cancer Together (TBCT) Platform, and member of the American Society of Surgical Oncology.
She is the Breast Associate Editor of the Journal of Surgical Oncology, and reviewer for The Breast, the European Journal of Surgical Oncology and the Annals of Surgical Oncology.

Dr. Rubio has published over 199 peer review manuscripts and many book chapters. She has participated in the WHO Global breast cancer initiative implementation framework: assessing, strengthening and scaling up of services for the early detection and management of breast cancer.
She has been the principal investigator in several clinical trials funded by the Spanish Health Minister, academic funding and EUBREAST trails.